Search results (7)
« Back to NewsAfrica’s change-makers: meet the Mastercard Foundation Scholars with big ambitions for the future
5 March 2025
By 2050, Africa will host a majority of the world's student-age population, shaping global futures. The Mastercard Foundation Scholars at Oxford's Africa Oxford Initiative receive full scholarships, rigorous education, leadership training, entrepreneurship support and networking, preparing them to lead Africa's and the world's future challenges and opportunities.
Myanmar-Thailand: Healthcare access without barriers
14 January 2025
In Myanmar, the United Nations reports that 3 million people have been displaced due to the ongoing civil war. The 2021 coup intensified conflicts and worsened the humanitarian crisis, forcing at least a hundred thousand to seek refuge and medical care in Thailand.
Professor Sassy Molyneux awarded five-year NIHR Global Health Research Professorship
2 August 2024
Professor Sassy Molyneux has received a prestigious five-year NIHR Global Health Research Professorship to study how to better protect frontline staff in international health research from moral distress. This is one of only five to seven such `flagship’ professorships awarded by the NIHR each year to outstanding scientists.
Shorter life expectancy during COVID-19 for India’s marginalised
23 July 2024
A new paper published in Science Advances finds that life expectancy in India was 2.6 years lower in 2020 than 2019, with women and marginalised social groups suffering the greatest declines.
Côte d’Ivoire makes history as first nation to deploy R21/Matrix-M™ Malaria Vaccine
15 July 2024
Today marks the official rollout of the new R21/Matrix-M™ malaria vaccine - co-developed by the University of Oxford and Serum Institute of India, leveraging Novavax’s Matrix-M™ adjuvant technology. In a historic step in the battle to beat malaria, the first official vaccination is due to take place in Abidjan, Côte d’Ivoire, this morning and will be subsequently rolled-out in 38 districts across the country.
Shipment of R21 malaria vaccine to Central African Republic marks latest milestone for child survival
12 June 2024
Last month, UNICEF delivered over 43,200 doses of the R21/Matrix-M malaria vaccine developed through collaboration between Oxford University’s Jenner Institute and Serum Institute of India leveraging by Novavax’s saponin-based adjuvant technology, by air to Bangui, Central African Republic, with further shipment of about 163,800 doses to follow, which is allocated for children in the CAR currently.
Forecasting how best to control and eliminate Neglected Tropical Diseases
26 April 2024
Neglected tropical diseases (NTDs) are a major cause of death, disability, and economic hardship worldwide, particularly in low- and middle-income countries. While many of these diseases are targeted for control, elimination, or eradication by 2030, achieving those targets will be challenging due to disruptions to programmes related to the COVID-19 pandemic and differences in disease transmission across regions, which requires tailoring interventions to local settings.